Figure 3 shows the distribution of the total number of subjects in the studies included in this review
Allows muscle gain without increasing lipid reserves
*Based on the average weight loss as reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity
You should not change your dosing regimen or stop taking tirzepatide as prescribed without first discussing with your healthcare provider
Once youve reached your 20-pound goal, AHC will help you decide whether to: Taper your dose and move into maintenance Cycle to every other week dosing Switch to a lower dose GLP-1 like Semaglutide Support metabolism with MIC+B12 or NAD+ therapies Learn how to maintain results: Stopping Semaglutide Safely Key Takeaways: Losing 20 Pounds on Tirzepatide Most users lose 20 pounds in 34 months Lifestyle habits make a huge difference Appetite and cravings drop by Week 34 Fatigue and nausea are most common early on Muscle-sparing is keyeat protein and move daily With Tirzepatide, weight loss becomes less about willpower and more about biology
doi: 10.3389/fcell.2025.1529901 Received 18 November 2024 Accepted 08 January 2025 Published 22 January 2025 Volume 13 - 2025 Edited by Yan Chun Li, The University of Chicago, United States Reviewed by Asuncion Romero-Molina, Consultant, Barcelona, Spain Vishwadeep Shelke, Tulane University, United States Updates Copyright 2025 Cheng, Wang, Ma and Zhou
